Related Experiment Video
Updated: Jul 19, 2026

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
Published on: February 15, 2018
The Effect of Probiotics on Phototherapy for Bilirubin Reduction in Term Neonates: A Randomized Controlled Trial
Fatemeh Eghbalian1, Mohamad Kazem Sabzehei1, Soroush Taheri Talesh2
1Departments of Pediatric, Hearing Disorders Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Insights
Combining probiotics with phototherapy significantly reduced treatment time and hospital stays for neonatal jaundice. This approach offers a more efficient treatment for term neonates suffering from elevated bilirubin levels.
Area of Science:
- Neonatology
- Gastroenterology
- Pediatric Medicine
Background:
- Neonatal jaundice is a common condition requiring effective treatment.
- Phototherapy is a standard treatment, but its efficacy can be enhanced.
- Combining therapies may offer improved outcomes for hyperbilirubinemia in newborns.
Purpose of the Study:
- To evaluate the efficacy of combined probiotics and phototherapy versus phototherapy alone in reducing bilirubin levels in term neonates.
- To compare treatment duration and hospitalization length between the two therapeutic approaches.
Main Methods:
- A randomized clinical trial involving 150 term neonates diagnosed with jaundice.
- Participants were assigned to receive either phototherapy with oral probiotics or phototherapy alone.
- Serum bilirubin levels, phototherapy duration, hospitalization length, and need for blood transfusion were monitored and compared.
Main Results:
- No significant difference in initial bilirubin levels or baseline characteristics between groups.
- The combination group showed significantly lower serum bilirubin levels by day three.
- The combinatory therapy group experienced shorter phototherapy durations (26.2 vs. 31.4 hours) and hospital stays (2.4 vs. 2.8 days).
Conclusions:
- Oral probiotics combined with phototherapy effectively reduce treatment duration and hospital stay in term neonates with jaundice.
- This combined approach presents a promising strategy for managing neonatal hyperbilirubinemia.
- Further research may explore the long-term benefits and optimal probiotic strains for neonatal jaundice.
Background:
This interventional study aimed to assess the impact of combining probiotics with phototherapy compared to using phototherapy alone on bilirubin reduction in term neonates hospitalized in neonatal wards in a pediatric hospital in western Iran.
Methods:
This clinical trial study included 150 term neonates with a gestational age of 37 to 42 weeks, birth weight of more than 2500 g, and diagnosed with neonatal jaundice. Patients were equally assigned to two groups of phototherapy (wavelength 420-450 nm) with oral probiotics (PediLact drop, 10 drops daily) and phototherapy alone through a simple random sampling method. Serum bilirubin levels (SBL) at the time of intervention, and 24, 48, and 72 hours later, duration of phototherapy, duration of hospitalization, and the need for blood transfusion were compared in the two groups. We used t-test and repeated analysis of variance to compare continuous variables. SPSS24 software was used to analyze the data. The significance level was set as 0.05.
Results:
There was no statistically significant difference found between the two groups regarding basic variables, gender, birth weight, gestational age, maternal age, and neonatal age at hospitalization time. On the first day of hospitalization, the mean serum bilirubin level (SBL) in the combinatory therapy group was 15.6 ± 1.7 mg/dl, while in the monotherapy group, it was 15.8 ± 1.6 mg/dl (p = 0.584). On the second day, the mean SBL in the combinatory therapy group was 11.2 ± 2.2, whereas in the monotherapy group, it was 12.4 ± 2.1. By the third day, these levels were 7.2 ± 0.9 and 7.8 ± 0.7, respectively, with a statistically significant difference between the two groups. Repeated analysis of variance testing confirmed a statistically significant decrease in serum bilirubin levels in both groups. The average length of hospital stay for the combinatory therapy group was 2.4 ± 0.5 days, compared to 2.8 ± 0.6 days in the phototherapy group (p = 0.001). In terms of phototherapy duration, the combinatory therapy group received treatment for 26.2 ± 9.9 hours, while the phototherapy group received it for 31.4 ± 10.3 hours (p = 0.001).
Conclusion:
The findings of the present study indicate that incorporating oral probiotics into phototherapy for neonatal jaundice (icterus) treatment is associated with a reduction in phototherapy duration and hospital stay.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Probiotics
Development of Human Microbiota
Microbiota Modulation by Antibiotics

